ClinicalTrials.gg
CompletedNCT07783724Updated Aug 25, 2026

Evaluating PEARL - a Personalized Exercise Assistant Using Reinforcement Learning (Walkmate Study)

An interventional study of Mobile App Push Notification (Random Selection) and Mobile App Push Notification (Behavior Science Heuristics) in Sedentary Lifestyle, sponsored by Fitbit LLC. Completed at 1 site in United States. Open to participants aged 22 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Fitbit LLC · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Feb 2024, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
13,463
Allocation
Randomized
Ages
22 Years to 60 Years
Sex
All
01

Study summary

To evaluate the impact of two personalized nudging strategies delivered as pop-up notifications via the Fitbit app on user step count. Specifically, to personalize the following parameters of the pop-up notification system: message content, and timing (hr of the day).

Read the detailed description

Phase 1 [Model calibration]: Recruit up to 1,000 Fitbit users for a 4 week pilot study. Nudge content and timing will be varied randomly in order to collect training data to prime the RL architecture prior to Phase 2.

Phase 2 [Performance evaluation]: Recruit up to 12,000 Fitbit users for a 60 day study in which they are randomized evenly between the following 4 arms:

[Control] No nudges Randomly selected nudges from the custom nudge library, delivered at constant time and frequency Behavior science (BS)-only nudge agent PEARL agent

Phase 3 [Micro-randomized Trial (MRT) \& LLM Feasibility]: Recruit up to 6,000 Fitbit users for a 60 day study in which they are randomized evenly between the following arms:

Behavior science Micro-randomized Trial (BS-MRT): Once per day users will be randomized across the below factors, and receive a message written by a behavior scientist (the same messages from Phase 1 \& 2).

COM-B Theme: 6 themes, and 1 control (no nudge) Time of day: 3 timeframes, and 1 control (no nudge) Large Language Model Micro-randomized Trial (LLM-MRT): Once per day users will be randomized across the below factors, and receive a message written by a large language model.

COM-B Theme: 6 themes, and 1 control (no nudge) Time of day: 3 timeframes, and 1 control (no nudge) Large Language Model + Reinforcement Learning (LLM-RL): Once per day, a reinforcement learning model will run to select the optimal COM-B theme and time of day (the same RL model from Phase 2 Arm 4). The nudges will be selected from a repository that is written by a large language model (LLM).

Primary Purpose:

Phase 1: Model calibration Phase 2: Evaluate performance on step count Phase 3: Micro-randomized Trial (MRT) \& LLM feasibility

02

Conditions studied

  • Sedentary Lifestyle

Keywords

  • activity
  • exercise
  • sedentary
  • artificial intelligence
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's enrollment of 13,463 is above the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Fitbit LLC is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 22-60 years
  • [For Phase 2 \& 3] Daily average steps 1 month prior to recruitment is less than 8000
  • Owns a Fitbit device \& smartphone with Fitbit app
  • Willing to share a month of step count data prior to enrollment data
  • Wear a Fitbit device regularly (user-reported)

Exclusion criteria

Exclusion Criteria:

  • Advised by a doctor to avoid exercising or limit physical activity
  • Current employees of Alphabet
  • [For phase 2] Have participated in Phase 1 of the study
  • [For phase 3] Have participated in Phase 1 or 2 of the study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
13,463 participants (actual)

Study arms

  • No intervention
    Control

    Participants use Fitbit devices, without the addition of the nudge intervention.

  • Active comparator
    Random

    Participants use Fitbit devices, with the addition of randomly deployed nudge interventions (random timing and theme).

    Behavioral: Mobile App Push Notification (Random Selection)

  • Active comparator
    Behavior Science

    Participants use Fitbit devices, with the addition of nudges deployed based on behavior science heuristics.

    Behavioral: Mobile App Push Notification (Behavior Science Heuristics)

  • Experimental
    Reinforcement Learning

    Participants use Fitbit devices, with the addition of nudges deployed based on a reinforcement learning algorithm.

    Behavioral: Mobile App Push Notification (RL)

Interventions

  • BehavioralMobile App Push Notification (Random Selection)

    Participants use Fitbit devices, with the addition of randomly deployed nudge interventions (random timing and theme).

    Also known as: Nudges

  • BehavioralMobile App Push Notification (Behavior Science Heuristics)

    Participants use Fitbit devices, with the addition of nudges deployed based on behavior science heuristics.

    Also known as: Nudges

  • BehavioralMobile App Push Notification (RL)

    Participants use Fitbit devices, with the addition of nudges deployed based on a reinforcement learning algorithm.

    Also known as: Nudges

06

What researchers measure

Primary outcomes

  1. Change in step count from baseline.

    The average daily step count during the final month minus baseline daily step count during one month before enrollment.

    Time frame: One month prior to enrollment (Baseline) to the second month post-enrollment (60 days total enrollment).

07

Study locations

1 site
  • Google Office (Digital Study)
    Mountain View, California 94043, United States
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Aug 2024, 6 months.

Of 741 interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2026
First posted
Aug 25, 2026
StartActual
Feb 26, 2024
Primary completionActual
Aug 26, 2024
CompletionActual
Aug 26, 2024
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07783724
Lead sponsor
Fitbit LLC
Collaborators
Google LLC.
Responsible party
Sponsor
First posted
Aug 25, 2026
Start date
Feb 26, 2024
Primary completion
Aug 26, 2024
Completion
Aug 26, 2024
Last update
Aug 25, 2026

Study contacts

James A Taylor, MD
principal investigator · Google LLC.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion